Does higher SHBG lower free and bioavailable testosterone even when total testosterone is normal?

Sex hormone-binding globulin (SHBG) is the primary transport protein for sex steroids in human circulation, and its concentration is a critical determinant of androgenic activity. For women, who have significantly lower total testosterone levels than men, the influence of SHBG on hormone availability is particularly pronounced, as it regulates the small fraction of testosterone that can actually exert physiological effects.

Clinical and effectiveness evidence

In clinical practice, total testosterone measurements often fail to reflect a patient's true androgen status because they include the large portion of the hormone bound tightly to SHBG.

• Research consistently shows that when SHBG levels rise—common in scenarios such as oral contraceptive use, hyperthyroidism, or certain genetic predispositions—the concentration of free and bioavailable testosterone decreases.
• Studies utilizing the Free Testosterone Index (FTI), calculated as (Total Testosterone / SHBG) × 100, demonstrate a strong inverse correlation between SHBG levels and the amount of active hormone.
• Clinical data indicates that individuals with high SHBG can present with symptoms of androgen deficiency even when their total testosterone levels fall squarely within the standard reference range. This occurs because the elevated protein "sinks" the available hormone into an inactive bound state.

Mechanistic explanations

The biological impact of SHBG is driven by its high binding affinity for testosterone, which dictates the equilibrium between bound and unbound states.

• Binding Affinity: SHBG binds testosterone with a dissociation constant (Kd) in the nanomolar range (approximately 1 nM to 44 nM). This represents a high-affinity interaction, several orders of magnitude stronger than the binding between testosterone and albumin (micromolar range).
• Sequestration: Approximately 66% to 78% of circulating testosterone in women is bound to SHBG. Because of the high affinity, this bound testosterone is not readily available to diffuse into target cells or interact with androgen receptors.
• Bioavailability: Only the "free" testosterone (unbound, ~1-2%) and "bioavailable" testosterone (free plus albumin-bound) are considered biologically active. As SHBG concentrations increase, the law of mass action dictates that more testosterone must bind to SHBG, directly depleting the free and bioavailable pools.

Bottom line

The claim is strongly supported by biochemical principles and clinical evidence. High SHBG levels effectively sequester testosterone, significantly reducing the free and bioavailable fractions. Consequently, total testosterone levels can be misleading, and measuring SHBG or calculating free testosterone is essential for an accurate assessment of androgen status, particularly when total levels are normal.